Jupiter Neurosciences Inc (JUNS)

$5.06 -0.12 (-2.32%)
Market Cap 3.99M
Revenue (ttm) 20,000.00
Net Income (ttm) -8.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -43,200.00%
Debt to Equity Ratio 0.00
Volume 29,600
Avg Vol 152,057
Day's Range N/A - N/A
Shares Out 770,000.00
Stochastic %K 32%
Beta 1.99
Analysts Strong Buy
Price Target $25.00

Company Profile

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinical trial for the treatment of Parkinson's disease; JNS108, which is in Phase II clinical trial for th...

Industry: Biotechnology
Sector: Healthcare
Phone: 561 406 6154
Address:
1001 North US Highway 1, Suite 504 Palm Beach Gardens, Jupiter, United States
littleimagination
littleimagination Aug. 18 at 2:55 PM
$JUNS Looks like Pharma stocks might go nuts this end of summer. I got SER, TELO, and JUNS,
0 · Reply
littleimagination
littleimagination Aug. 18 at 2:39 PM
$JUNS I'm in JUNS now. With such a tiny float of shares, hopefully they will make the shorts squeeze this to the stratosphere. Smallest number of shares for a stock in the entire market! Booyah! A few big buyers and this will do an RGC, SMX!
1 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:41 PM
$AKAN $CNSP $PAVM $ZOOZ $JUNS gemc
0 · Reply
UnknownABC
UnknownABC Aug. 17 at 2:54 PM
$JUNS 100M deal and nothing happens!?
1 · Reply
Knucklehead_
Knucklehead_ Aug. 15 at 2:26 AM
$JUNS None of this is making sense. First, short traders have tried to bankrupt the company since January 2026. Their misinformation campaign and shorting. Many of the failure to deliver reports are indications of potential foul play. Now, the company signed a 100M deal and should have skyrocketed after the reverse split. The misinformation machine is working full speed. Unfortunately this seems normal for other biotechs I have purchased shares of in the past. This illegal behavior was coined by Adam Left. Adam has been convicted of his crimes and is awaiting sentencing. https://www.justice.gov/opa/pr/activist-short-seller-convicted-21m-stock-market-manipulation-scheme
0 · Reply
UnknownABC
UnknownABC Aug. 14 at 10:58 PM
$JUNS 10-Q https://www.sec.gov/ix?doc=/Archives/edgar/data/1679628/000149315226038463/form10-q.htm
0 · Reply
weezled
weezled Aug. 14 at 9:43 PM
$JUNS lol and its still on its way back to sub $1.X
0 · Reply
ZebraCyclops
ZebraCyclops Aug. 14 at 6:30 PM
$JUNS 🤣
0 · Reply
Curlyroprim1
Curlyroprim1 Aug. 14 at 4:28 PM
$JUNS told u
0 · Reply
LongisHard
LongisHard Aug. 14 at 4:04 PM
$JUNS somebody convince me
0 · Reply
Latest News on JUNS
Jupiter Neurosciences Inc trading halted, news pending

2026-08-06T23:50:29.000Z - 12 days ago

Jupiter Neurosciences Inc trading halted, news pending

Jupiter Neurosciences announces 1-for-75 reverse stock split

2026-08-05T13:58:47.000Z - 14 days ago

Jupiter Neurosciences announces 1-for-75 reverse stock split

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

Aug 5, 2026, 8:00 AM EDT - 14 days ago

Jupiter Neurosciences, Inc. Announces Reverse Stock Split

Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences

2026-07-23T15:10:37.000Z - 26 days ago

Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences

ATAI CMND GHRS HELP LLY NRXP

Jupiter Neurosciences Stock (JUNS) Jumps on a New License Deal

2026-07-21T18:19:53.000Z - 4 weeks ago

Jupiter Neurosciences Stock (JUNS) Jumps on a New License Deal

PharmAla enters up to $100M ALA-002 license pact with Jupiter Neurosciences

2026-07-21T11:15:16.000Z - 4 weeks ago

PharmAla enters up to $100M ALA-002 license pact with Jupiter Neurosciences

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

Jul 21, 2026, 7:13 AM EDT - 4 weeks ago

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson

Jul 7, 2026, 8:58 AM EDT - 6 weeks ago

Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson

Jupiter Neurosciences files to sell 16M shares of common stock for holders

2026-06-26T20:35:09.000Z - 7 weeks ago

Jupiter Neurosciences files to sell 16M shares of common stock for holders

Jupiter Neurosciences commences patient enrollment in RESET trial

2026-05-27T12:09:17.000Z - 3 months ago

Jupiter Neurosciences commences patient enrollment in RESET trial

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson's Disease

May 27, 2026, 7:30 AM EDT - 3 months ago

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson's Disease

D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering

May 26, 2026, 12:00 PM EDT - 3 months ago

D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

May 21, 2026, 5:15 PM EDT - 3 months ago

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

Jupiter Neurosciences announces pricing of $2M registered direct offering

2026-05-20T18:40:09.000Z - 3 months ago

Jupiter Neurosciences announces pricing of $2M registered direct offering

Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering

May 20, 2026, 2:38 PM EDT - 3 months ago

Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering

Jupiter Neurosciences to acquire licensing rights to ALA-002 for $3.33M upfront

2026-05-20T12:17:05.000Z - 3 months ago

Jupiter Neurosciences to acquire licensing rights to ALA-002 for $3.33M upfront

Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

May 20, 2026, 7:38 AM EDT - 3 months ago

Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit

May 4, 2026, 11:30 AM EDT - 3 months ago

Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit

Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14

Apr 13, 2026, 8:00 PM EDT - 4 months ago

Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14

Jupiter Neurosciences to present progress at Mar-a-Lago investor dinner

2026-02-25T13:48:57.000Z - 6 months ago

Jupiter Neurosciences to present progress at Mar-a-Lago investor dinner

Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago

Feb 25, 2026, 8:30 AM EST - 6 months ago

Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago

Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution

Feb 23, 2026, 9:30 AM EST - 6 months ago

Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution

Jupiter Neurosciences expands Nugevia addressable market

2026-01-28T11:30:56.000Z - 7 months ago

Jupiter Neurosciences expands Nugevia addressable market

Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users

Jan 28, 2026, 6:00 AM EST - 7 months ago

Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users

Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference

Jan 27, 2026, 10:45 AM EST - 7 months ago

Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference

Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6

Dec 23, 2025, 8:00 AM EST - 8 months ago

Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6

Jupiter Neurosciences to Participate in NobleCon21

Dec 2, 2025, 4:15 PM EST - 9 months ago

Jupiter Neurosciences to Participate in NobleCon21

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

Oct 27, 2025, 8:30 AM EDT - 10 months ago

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

Aug 19, 2025, 8:12 AM EDT - 1 year ago

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jul 23, 2025, 8:00 AM EDT - 1 year ago

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 10, 2025, 4:05 PM EDT - 1 year ago

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jun 30, 2025, 3:15 PM EDT - 1 year ago

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Feb 4, 2025, 9:25 AM EST - 1 year ago

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jan 30, 2025, 8:00 AM EST - 1 year ago

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Dec 4, 2024, 4:56 PM EST - 1 year ago

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Dec 2, 2024, 7:00 PM EST - 1 year ago

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

littleimagination
littleimagination Aug. 18 at 2:55 PM
$JUNS Looks like Pharma stocks might go nuts this end of summer. I got SER, TELO, and JUNS,
0 · Reply
littleimagination
littleimagination Aug. 18 at 2:39 PM
$JUNS I'm in JUNS now. With such a tiny float of shares, hopefully they will make the shorts squeeze this to the stratosphere. Smallest number of shares for a stock in the entire market! Booyah! A few big buyers and this will do an RGC, SMX!
1 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:41 PM
$AKAN $CNSP $PAVM $ZOOZ $JUNS gemc
0 · Reply
UnknownABC
UnknownABC Aug. 17 at 2:54 PM
$JUNS 100M deal and nothing happens!?
1 · Reply
Knucklehead_
Knucklehead_ Aug. 15 at 2:26 AM
$JUNS None of this is making sense. First, short traders have tried to bankrupt the company since January 2026. Their misinformation campaign and shorting. Many of the failure to deliver reports are indications of potential foul play. Now, the company signed a 100M deal and should have skyrocketed after the reverse split. The misinformation machine is working full speed. Unfortunately this seems normal for other biotechs I have purchased shares of in the past. This illegal behavior was coined by Adam Left. Adam has been convicted of his crimes and is awaiting sentencing. https://www.justice.gov/opa/pr/activist-short-seller-convicted-21m-stock-market-manipulation-scheme
0 · Reply
UnknownABC
UnknownABC Aug. 14 at 10:58 PM
$JUNS 10-Q https://www.sec.gov/ix?doc=/Archives/edgar/data/1679628/000149315226038463/form10-q.htm
0 · Reply
weezled
weezled Aug. 14 at 9:43 PM
$JUNS lol and its still on its way back to sub $1.X
0 · Reply
ZebraCyclops
ZebraCyclops Aug. 14 at 6:30 PM
$JUNS 🤣
0 · Reply
Curlyroprim1
Curlyroprim1 Aug. 14 at 4:28 PM
$JUNS told u
0 · Reply
LongisHard
LongisHard Aug. 14 at 4:04 PM
$JUNS somebody convince me
0 · Reply
MoneyorBagHolder
MoneyorBagHolder Aug. 14 at 4:02 PM
$JUNS Almost became an instant bag holder. Had limit order of 1000 shares at $6.15. I did cancel in time. I am showing $5.52 and am expecting a further decline. The best transaction would had been buy and sell yesterday.
1 · Reply
The_Assassin
The_Assassin Aug. 14 at 3:39 PM
$JUNS nice loading zone $5.50 dont miss out
0 · Reply
mmart32
mmart32 Aug. 14 at 3:16 PM
$JUNS added here for a run towards $8+, $13.25 50 day moving avg
0 · Reply
Knucklehead_
Knucklehead_ Aug. 14 at 2:28 PM
$JUNS Normal pattern. Bears try to control in the morning. Bulls turn in the afternoon. Down 1,000 watchers but not out. Run bulls run! We only need 10%+ to set off scanners, then fly time. Cheers 🥂
0 · Reply
fortuneseller
fortuneseller Aug. 14 at 1:54 PM
$JUNS and Back to 6 again...
0 · Reply
Brumm
Brumm Aug. 14 at 1:51 PM
$JUNS
0 · Reply
Core786
Core786 Aug. 14 at 11:53 AM
$JUNS just goes to show spamming boards to create a pump never works out……… you know who I’m talking about don’t do it again!!!
1 · Reply
TATTED_KEN
TATTED_KEN Aug. 14 at 11:15 AM
$LBGJ she’s moving today from the low $3S. Trimming on the way up. Didn’t get my $7, but I’m good with $5. Take what the market gives you. $MSS is today finally our day? 🤞🏼 Watching $JUNS.
0 · Reply
LongisHard
LongisHard Aug. 14 at 11:09 AM
$JUNS $6.75 and its blast off otherwise sell off ?
0 · Reply
Lincolnshire
Lincolnshire Aug. 14 at 11:07 AM
$JUNS So far this looks like a 1 day pump and dump. Yesterday was the Pump, so you know what today is.
0 · Reply
SaladMan00
SaladMan00 Aug. 14 at 10:16 AM
$JUNS today moon or next week?
0 · Reply
Mleh123
Mleh123 Aug. 14 at 10:15 AM
$JUNS lets go!
0 · Reply